https://blog.billiondollarblindspot.com/p/ucb-candid-therapeutics-autoimmune-investment-thesisThe Billion Dollar Blindspoten2026-05-12T06:06:15+00:00UCB Just Paid $2.2 Billion for an Autoimmune Platform. The Indication List Tells You More Than the Deal Price.